Saptak Chem And Business Q2 FY27 results: net loss narrows to ₹0.01 crore

How did Saptak Chem And Business perform in Q2 FY27?

Saptak Chem And Business reported standalone revenue of ₹0 crore in Q2 FY27, unchanged from Q2 FY26 and Q1 FY27. It recorded an EBITDA loss of ₹0.01 crore, a profit before tax loss of ₹0.01 crore and a net loss of ₹0.01 crore. Basic EPS was ₹0.05, compared with ₹0.18 in Q2 FY26 and ₹0.16 in Q1 FY27. No consolidated figures were given in the filing.

Total expenses were ₹0.01 crore in Q2 FY27, compared with ₹0.02 crore in Q2 FY26 and ₹0.05 crore in Q1 FY27. The quarterly result therefore showed lower expenses than both comparison periods, although revenue remained at ₹0 crore. The board approved the standalone unaudited results and the auditors’ limited review report on 28 October 2026.

What changed in Saptak Chem And Business' costs and profit?

Against Q2 FY26, total expenses fell by ₹0.01 crore to ₹0.01 crore, a 50.0% decrease. Employee cost, finance cost, depreciation and other expenses were each unchanged, while cost of materials and other income also remained unchanged. There was no exceptional item, and tax was unchanged at ₹0 crore.

Against Q1 FY27, total expenses fell by ₹0.04 crore to ₹0.01 crore, an 80.0% decrease. Other expenses declined by ₹0.03 crore to ₹0.01 crore, while employee cost, finance cost, depreciation and cost of materials were unchanged. Other income and tax were unchanged, and there was no exceptional item. The filing did not state a reason for the quarterly movement.

How did the first half of FY27 go?

In the first half of FY27, revenue and total income were both ₹0 crore, unchanged from H1 FY26. Profit before tax and net loss were each ₹0.06 crore, compared with a net loss of ₹0.08 crore in H1 FY26. Basic EPS was ₹0.59, compared with ₹0.73 in H1 FY26. The filing also reported H1 FY26 revenue of ₹0 crore and total income of ₹0 crore.

What do the balance sheet and cash flow show?

As on 30 September 2026, total assets were ₹2.66 crore, compared with ₹1.15 crore as on 31 March 2026. Total equity was ₹0.01 crore against negative equity of ₹1.51 crore, while borrowings were ₹2.66 crore compared with ₹2.65 crore. Cash fell to ₹0.01 crore from ₹0.25 crore, and inventories and trade receivables were unchanged at ₹0 crore.

H1 FY27 operating cash flow was an outflow of ₹1.82 crore, compared with an outflow of ₹0.09 crore in H1 FY26. Investing cash flow was ₹0 crore, while financing cash flow was an inflow of ₹1.58 crore, compared with ₹0.18 crore in H1 FY26. Capital expenditure was ₹0 crore in both periods, and closing cash was not given for H1 FY27.

How has Saptak Chem And Business done over the last 8 quarters?

Across the reported quarterly sequence, revenue remained ₹0 crore from Q3 FY25 through Q2 FY27. The net loss was lowest in Q2 FY27 at ₹0.01 crore and highest in Q3 FY26 at ₹1.06 crore, before narrowing to ₹0.12 crore in Q4 FY26 and ₹0.05 crore in Q1 FY27. EBITDA margins were not reported for the quarterly trend, so the direction of revenue and profit cannot be described beyond the figures shown.

How did Saptak Chem And Business shares react?

How did other Trading & Distributors companies do?

Among 25 other Trading & Distributors companies compared for the quarter, the median revenue growth was 46.8%. The number of peers growing faster than Saptak Chem And Business and the number growing slower than the company were not provided in the facts. Of the 36 peers for which profit was compared, 20 reported higher profit.